Menu
GeneBe

22-23787170-A-C

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2

The NM_003073.5(SMARCB1):c.1A>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000696 in 1,437,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

SMARCB1
NM_003073.5 start_lost

Scores

5
3
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.92
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMARCB1NM_003073.5 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/9 ENST00000644036.2
SMARCB1NM_001362877.2 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/9
SMARCB1NM_001317946.2 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/9
SMARCB1NM_001007468.3 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMARCB1ENST00000644036.2 linkuse as main transcriptc.1A>C p.Met1? start_lost 1/9 NM_003073.5 A1Q12824-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
6.96e-7
AC:
1
AN:
1437314
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
716004
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.15e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeNov 03, 2023This sequence change affects the initiator methionine of the SMARCB1 mRNA. The next in-frame methionine is located at codon 2, 3, and 4. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with ovarian cancer (PMID: 29625052). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.14
Cadd
Benign
21
Dann
Benign
0.92
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.93
D
M_CAP
Pathogenic
0.96
D
MetaRNN
Pathogenic
0.97
D;D;D;D;D;D
MetaSVM
Uncertain
0.25
D
MutationTaster
Benign
0.89
D;D;D;D
PROVEAN
Benign
-0.38
N;.;N;N;N;N
REVEL
Uncertain
0.57
Sift
Pathogenic
0.0
D;.;D;D;D;D
Sift4G
Benign
0.55
T;.;T;T;T;T
Polyphen
0.0, 0.17
.;B;B;.;.;B
Vest4
0.81
MutPred
0.86
Loss of MoRF binding (P = 0.0683);Loss of MoRF binding (P = 0.0683);Loss of MoRF binding (P = 0.0683);Loss of MoRF binding (P = 0.0683);Loss of MoRF binding (P = 0.0683);Loss of MoRF binding (P = 0.0683);
MVP
0.98
ClinPred
1.0
D
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.91
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr22-24129357; API